Clinical Trials in Arizona

Showing 3881-3900 of 16,770 trials

A Study of LY3549492 in Healthy Weight Adult Participants

NCT07085468

The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.

Healthy

Eli Lilly and Company1 participantsStarted Jul 2025

Scottsdale, Arizona, United States • Covina, California, United States • Northridge, California, United States +18 more locations

TERMINATEDPhase 231 miles

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

NCT07030868

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.

ObesityOverweightType 2 Diabetes

Eli Lilly and Company1 participantsStarted Jun 2025

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Greenbrae, California, United States +39 more locations

A Study of LY3549492 in Healthy Weight Adult Participants

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Find Trials by Condition in Arizona

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Mitral Valve Screening Survey

Long-Term Evaluation of BIIB067 (Tofersen)

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

MarginProbe 2.0 Data Collection Protocol

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis